2023
DOI: 10.3390/molecules28031324
|View full text |Cite
|
Sign up to set email alerts
|

Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs

Abstract: Central nervous system (CNS) disorders are a therapeutic area in drug discovery where demand for new treatments greatly exceeds approved treatment options. This is complicated by the high failure rate in late-stage clinical trials, resulting in exorbitant costs associated with bringing new CNS drugs to market. Computer-aided drug design (CADD) techniques minimise the time and cost burdens associated with drug research and development by ensuring an advantageous starting point for pre-clinical and clinical asse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 147 publications
0
7
0
Order By: Relevance
“…In either case, our data highlight the possibility that appropriate chemical modification of the FX backbone may result in new compounds capable of addressing more of the residues at the ATP binding site of PI3K. Thus, our current findings may inspire and guide intelligent drug design studies, 89,90 resulting in new FX‐derivatives with improved potency/efficacy towards PI3K.…”
Section: Discussionmentioning
confidence: 73%
“…In either case, our data highlight the possibility that appropriate chemical modification of the FX backbone may result in new compounds capable of addressing more of the residues at the ATP binding site of PI3K. Thus, our current findings may inspire and guide intelligent drug design studies, 89,90 resulting in new FX‐derivatives with improved potency/efficacy towards PI3K.…”
Section: Discussionmentioning
confidence: 73%
“…Deep learning in structure-activity relationships (SAR) involves the application of multilayer neural networks to understand and predict how the structure of chemical compounds affects their biological activity. 92,[102][103][104][105] This approach is particularly revolutionary in the field of drug discovery, where identifying compounds with desired biological effects is both critical and challenging.…”
Section: Deep Learning In Structure-activity Relationships (Sar)mentioning
confidence: 99%
“…Computer-aided drug design approaches, such as ligand-based and structure-based methods, represent widely exploited tools to accelerate the discovery of novel bioactive compounds [ 14 , 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%